NAP1L5 and Alzheimer disease: Our previous predictions have shown that NAP1L5 is negatively correlated with the expression level of AQP1, which has been suggested as a key regulator involved in the pathogenesis of AD (Misawa et al., 2008; Ijaz et al., 2021; Park et al., 2021).